Evidence map›Paper›PMID 28879633›Full record

ReviewCurrent cardiology reports2017

The Initial Evaluation and Management of a Patient with Heart Failure.

Jamael Hoosain, Jabar Whittier, Farhan Hasni, Shelley Hankins

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current cardiology reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jamael HoosainDrexel University College of Medicine, 245 N 15th Street, Philadelphia, PA, 19102, USA.
Jabar WhittierDrexel University College of Medicine, 245 N 15th Street, Philadelphia, PA, 19102, USA.
Farhan HasniDrexel University College of Medicine, 245 N 15th Street, Philadelphia, PA, 19102, USA.
Shelley HankinsDrexel University College of Medicine, 245 N 15th Street, Philadelphia, PA, 19102, USA. shankins@drexelmed.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewThe goal of this review is to summarize and discuss a thorough and effective manner in the evaluation of the patient with heart failure. RECENT

findingsHeart failure is a prevalent disease worldwide and while the diagnosis of heart failure has remained relatively unchanged via a careful history and physical examination, identification of the etiology of the heart failure and treatment has made significant advances. Mechanical circulatory support (MCS), neprilysin inhibitors, and chronic resynchronization therapy (CRT) are just some of the relatively recent therapies afforded to assist heart failure patients. Heart failure is a complicated, multifactorial diagnosis that requires a careful history and physical for diagnosis with the support of laboratory tests. While the prognosis for heart failure patients remains poor in comparison to other cardiovascular disease and even certain cancers, new advancements in therapy have shown survival and quality of life improvement.

Indexed as

Cardiac Resynchronization TherapyEnzyme InhibitorsHeart-Assist DevicesHeart FailureHumansNeprilysinPrognosisQuality of LifeSurvival AnalysisEnzyme InhibitorsNeprilysinCardiomyopathyHeart failureHypertension

Identifiers

PMID28879633

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.